Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Intuitive Surgical (ISRG)

Nasdaq Health Care Health Care Equipment S&P 500Nasdaq-100
$452.80
-15.72 (-3.36%)
Close of Nov 06, 2026 · end-of-day data
Source: Intuitive Surgical's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$2.71B$3.14B$3.72B$4.48B$4.36B$5.71B$6.22B$7.12B$8.35B$10.06B
Cost of revenue$814.30M$934.80M$1.12B$1.37B$1.50B$1.75B$2.03B$2.39B$2.72B$3.42B
Gross profit$1.89B$2.20B$2.60B$3.11B$2.86B$3.96B$4.20B$4.73B$5.63B$6.64B
Research & development$239.60M$328.60M$418.10M$557.30M$595.10M$671.00M$879.00M$998.80M$1.15B$1.31B
Selling, general & admin$703.60M$810.50M$986.60M$1.18B$1.22B$1.47B$1.74B$1.96B$2.14B$2.38B
Operating income$949.70M$1.06B$1.20B$1.37B$1.05B$1.82B$1.58B$1.77B$2.35B$2.95B
Pre-tax income$985.30M$1.10B$1.28B$1.50B$1.21B$1.89B$1.61B$1.96B$2.67B$3.31B
Income tax$247.00M$433.90M$154.50M$120.40M$140.20M$162.20M$262.40M$141.60M$336.30M$434.80M
Net income$738.30M$670.90M$1.13B$1.38B$1.06B$1.70B$1.32B$1.80B$2.32B$2.86B
EBITDA$1.02B$1.15B$1.31B$1.53B$1.27B$2.10B$1.90B$2.15B$2.79B$3.55B
EPS (basic)$6.43$6.01$9.92$3.98$3.02$4.79$3.72$5.12$6.54$8.00
EPS (diluted)$6.26$5.77$9.49$3.85$2.94$4.66$3.65$5.03$6.42$7.87
Diluted shares117.90M116.30M118.80M358.40M361.00M365.80M362.00M357.40M362.00M362.70M
Gross margin69.9%70.2%69.9%69.4%65.6%69.3%67.4%66.4%67.5%66.0%
Operating margin35.1%33.9%32.2%30.7%24.1%31.9%25.3%24.8%28.1%29.3%
Net margin27.3%21.4%30.3%30.8%24.3%29.9%21.3%25.2%27.8%28.4%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$1.04B$648.20M$857.90M$1.17B$1.62B$1.29B$1.58B$2.75B$2.03B$3.37B
Short-term investments$1.52B$1.31B$2.21B$2.05B$3.49B$2.91B$2.54B$2.47B$1.99B$2.57B
Receivables$430.20M$507.90M$682.30M$645.20M$645.50M$782.70M$942.10M$1.13B$1.23B$1.53B
Inventory$182.30M$241.20M$409.00M$595.50M$601.50M$587.10M$893.20M$1.22B$1.49B$1.84B
Total current assets$3.25B$2.81B$4.33B$4.66B$6.63B$5.84B$6.25B$7.89B$7.11B$9.78B
Goodwill$201.10M$201.10M$240.60M$307.20M$336.70M$343.60M$348.50M$348.70M$347.50M$370.30M
Total assets$6.49B$5.78B$7.85B$9.73B$11.17B$13.55B$12.97B$15.44B$18.74B$20.46B
Total current liabilities$596.50M$662.80M$820.60M$1.03B$965.20M$1.15B$1.42B$1.66B$1.75B$2.01B
Total liabilities$709.10M$996.40M$1.16B$1.45B$1.41B$1.60B$1.86B$2.04B$2.21B$2.52B
Shareholders' equity$5.78B$4.78B$6.68B$8.26B$9.73B$11.90B$11.04B$13.31B$16.43B$17.82B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$1.09B$1.14B$1.17B$1.60B$1.48B$2.09B$1.49B$1.81B$2.42B$3.03B
Capital expenditures$53.90M$190.70M$187.40M$425.60M$341.50M$339.50M$532.40M$1.06B$1.11B$539.80M
Free cash flow$1.03B$953.20M$982.20M$1.17B$1.14B$1.75B$958.40M$749.60M$1.30B$2.49B
Investing cash flow-$1.28B$378.70M-$1.05B-$1.15B-$940.60M-$2.46B$1.37B-$360.10M-$3.27B$665.80M
Financing cash flow$514.40M-$1.91B$126.30M-$168.40M-$85.70M$43.00M-$2.57B-$287.60M$150.90M-$2.36B
Share buybacks$42.50M$2.27B$0$269.50M$134.30M$0$2.61B$416.30M$0$2.30B
Stock-based compensation$177.60M$209.10M$261.20M$335.80M$395.40M$449.20M$513.20M$592.80M$676.80M$788.20M
Depreciation & amortization$70.70M$82.10M$105.90M$157.00M$221.00M$280.00M$326.00M$382.00M$439.00M$600.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.